Archive


Category: Cardinal Health

  • Cardinal Health Continues to Expand at-Home Solutions Business

    Cardinal Health Inc. (NYSE: CAH) has been investing heavily into its very own home-based solutions business – Cardinal Health at-Home Solutions – for some time now. On Thursday, the company announced that it was taking another step in the expansion of that business. It has opened up a new distribution warehouse in Central Ohio as […]

  • Is It Finally Time for Hospital-at-Home or is Time Up?

    Karen Conway, VP of Healthcare Value, Global Healthcare Exchange (GHX) All the signs point to a bright and expansive future for hospital-at-home programs, which have been growing steadily since the Centers for Medicare and Medicaid (CMS) created the Acute Hospital at Home waiver program in November 2020. As of March, nearly 100 health systems and […]

  • Cardinal Health Investing Heavily in Its At-Home Care Business

    One of the largest companies in the U.S. has carved out significant space for at-home care innovation. That company is Cardinal Health Inc. (NYSE: CAH), which has let Cardinal Health at-Home Solutions pave its own way in a budding home-based care market. The company – which posted over $160 billion in revenue last year – […]

  • J&J, wholesalers see an end to their opioid liability hangover

    Johnson & Johnson and the ‘big three’ US pharm wholesalers say they are close to finalising a $26 billion settlement that could allow them to finally put years of litigation over their role in fuelling the opioid crisis behind them. The settlement is the largest to date among thousands of opioid-related lawsuits brought against pharma […]

  • Medically Home Looks to Expand Business Model After Landing $110M Strategic Investment

    The hospital-at-home enabler Medically Home announced Monday that it was on the receiving end of another strategic investment, this one totaling $110 million. The Mayo Clinic and Kaiser Permanente made a $100 million investment into Medically Home in May of 2021. Before that, the company had raised $64 million. The most recent investment was led […]

  • Top 20 Medical Device Companies Based on 2020 Revenue

    The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020, the companies have shown growth resulted from a rise in the number of healthcare facilities, healthcare expenditure, technological advancements. Medtronic remains at the top of […]

  • Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching

    What You Should Know: – Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, […]

  • PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

    Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, mRNA Translation Modulators, Neurological Diseases Kiniksa’s Arcalyst (rilonacept) Receives the US FDA’s Approval for the Treatment of Pericarditis Published: Mar 19, 2021 | Tags: Kiniksa, Arcalyst (rilonacept), Receives, US, FDA, […]

  • PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

    Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, mRNA Translation Modulators, Neurological Diseases Kiniksa’s Arcalyst (rilonacept) Receives the US FDA’s Approval for the Treatment of Pericarditis Published: Mar 19, 2021 | Tags: Kiniksa, Arcalyst (rilonacept), Receives, US, FDA, […]

  • Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

    Shots: Cardinal Health signed an agreement to divest its Cordis medical device business to H&F for ~ $1B including liabilities and working capital accounts. The transaction is expected to close in the H1’ 22 Following the completion of the agreement, H&F will assume most of the Cordis assets and liabilities while Cardinal Health will retain […]

  • Healthcare PE Firm Heritage Group Launches $317M Health Tech Fund

    Partners David McClellan, Rock Morphis, Paul Wallace (Left to Right) What You Should Know: – Healthcare private equity firm Heritage Group launches a $300M fund to invest in high-growth healthcare services and technology companies. – Heritage is backed by some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare […]